KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Staar Surgical (STAA) Common Equity (2016 - 2025)

Historic Common Equity for Staar Surgical (STAA) over the last 16 years, with Q3 2025 value amounting to $353.8 million.

  • Staar Surgical's Common Equity fell 1736.47% to $353.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $353.8 million, marking a year-over-year decrease of 1736.47%. This contributed to the annual value of $397.3 million for FY2024, which is 294.88% up from last year.
  • According to the latest figures from Q3 2025, Staar Surgical's Common Equity is $353.8 million, which was down 1736.47% from $336.6 million recorded in Q2 2025.
  • Staar Surgical's 5-year Common Equity high stood at $428.1 million for Q3 2024, and its period low was $197.2 million during Q1 2021.
  • In the last 5 years, Staar Surgical's Common Equity had a median value of $337.7 million in 2023 and averaged $325.5 million.
  • In the last 5 years, Staar Surgical's Common Equity surged by 3431.99% in 2021 and then plummeted by 1772.9% in 2025.
  • Quarter analysis of 5 years shows Staar Surgical's Common Equity stood at $258.6 million in 2021, then increased by 29.99% to $336.1 million in 2022, then rose by 14.83% to $386.0 million in 2023, then rose by 2.95% to $397.3 million in 2024, then fell by 10.96% to $353.8 million in 2025.
  • Its Common Equity was $353.8 million in Q3 2025, compared to $336.6 million in Q2 2025 and $350.0 million in Q1 2025.